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Abstract
An investigation into the causes of canine infectious respiratory disease was carried out in a large rehoming kennel. Tissue samples taken
from the respiratory tract of diseased dogs were tested for the presence of coronaviruses using RT–PCR with conserved primers for the
polymerase gene. Sequence analysis of four positive samples showed the presence of a coronavirus with high similarity to both bovine and
human coronavirus (strain OC43) in their polymerase and spike genes, whereas there was a low similarity to comparable genes in the enteric
canine coronavirus. This canine respiratory coronavirus (CRCV) was detected by RT–PCR in 32/119 tracheal and 20/119 lung samples, with
the highest prevalence being detected in dogs with mild clinical symptoms. Serological analysis showed that the presence of antibodies
against CRCV on the day of entry into the kennel decreased the risk of developing respiratory disease.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Canine infectious respiratory disease (CIRD) is a highly
contagious disease, especially in dogs housed in groups in
rehoming centers and boarding or training kennels. Many
dogs suffer from a mild cough and recover after a short
time; however, in some cases a severe bronchopneumonia
can develop (Appel and Binn, 1987). In addition to causing
distress to the dogs, CIRD also delays rehoming at rescue
centers and causes disruption of schedules in training ken-
nels as well as incurring considerable treatment costs.
CIRD is considered to be a multifactorial disease be-
cause it usually occurs when dogs from different origins are
brought together, a situation that exposes the dogs to a
variety of different microorganisms as well as an unfamiliar
environment. The infectious agents that have been consid-
ered the major causative pathogens involved are canine
parainfluenzavirus (CPIV) (Binn et al., 1967), canine ade-
novirus type 2 (CAV-2) (Ditchfield et al., 1962), and the
bacterium Bordetella bronchiseptica (Bemis et al., 1977a;
Keil et al., 1998). Also, canine herpesvirus, human reovirus,
and mycoplasma species have been isolated from dogs with
symptoms of CIRD (Karpas et al., 1968; Lou and Wenner,
1963; Randolph et al., 1993). Experimental infection of
dogs with single infectious agents has been shown to cause
only mild respiratory symptoms but failed to reproduce the
severe disease that can be seen in natural outbreaks, sup-
porting the theory that the pathogenesis of CIRD is multi-
factorial (Appel and Percy, 1970; Karpas et al., 1968; Bemis
et al., 1977b).
Vaccines are available against some of the infectious
agents that have been found to be associated with this
disease, namely, Bordetella bronchiseptica as well as CPIV
and CAV-2. Despite the use of these vaccines, CIRD is still
prevalent in kennels worldwide, suggesting that additional
viruses or bacteria may be involved in the disease.
Members of the family Coronaviridae are enveloped
viruses, 80–160 nm in diameter, containing a linear posi-
tive-stranded RNA genome. The structural proteins of coro-
naviruses are the spike glycoprotein, the membrane glyco-
protein, and the nucleocapsid protein. The hemagglutinin/
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esterase glycoprotein is found only on the surface of group
2 coronaviruses (e.g., bovine coronavirus and murine hep-
atitis virus) (Spaan et al., 1988).
The polymerase gene of coronaviruses is known to be
highly conserved. It has therefore previously been used for
phylogenetic analysis of this virus family (Stephensen et al.,
1999). A possible role of Coronaviridae in the pathogenesis
of CIRD was investigated in this study because members of
this family are known to cause respiratory disease in hu-
mans as well as cattle, swine, and poultry (Ma¨kela¨ et al.,
1998; Pensaert et al., 1986; Ignjatovic and Sapats, 2000). In
cattle, bovine respiratory coronavirus is associated with
shipping fever, a multifactorial respiratory disease similar to
CIRD (Storz et al., 2000). Canine coronaviruses are re-
ported to cause acute diarrhea mainly in young dogs (Ten-
nant et al., 1993). However, one study reports the detection
of canine coronavirus in dogs with respiratory disease and
describes the isolation of the virus from one lung sample
and three intestinal samples (Binn et al., 1979).
This investigation sought to detect coronaviruses associ-
ated with CIRD in a large kenneled dog population with a
history of endemic respiratory disease, using virus culture
and PCR techniques as well as serology on paired serum
samples.
Results
PCR using consensus primers for the coronavirus RNA
polymerase gene
Using the primers Conscoro5 and Conscoro6, we ana-
lyzed the cDNA obtained from 40 tracheal samples by
RT–PCR. Of these, 7 were found to be positive by PCR and
subsequent hybridization (17.5%). The PCR products were
cloned and sequenced and the sequence data were compared
to available viral sequences using the FASTA similarity
search program (Pearson, 1990).
Comparison of the coronavirus cDNA polymerase se-
quence obtained from four of the canine tracheal samples to
other coronavirus sequences revealed that they were most
similar to sequence data from bovine coronavirus (GenBank
Accession No. AF 220295) and human coronavirus strain
OC 43 (GenBank Accession No. AF 124989). The identity
in the analyzed 251-bp sequence was 98.8% for the bovine
and 98.4% for the human coronavirus polymerase gene,
whereas it was only 68.53% for canine coronavirus (strain
1–71).
An alignment of the novel sequence with the correspond-
ing sequences of 11 coronaviruses and phylogenetic analy-
sis using the maximum parsimony method resulted in the
consensus tree shown in Fig. 1. The cDNA sequence ob-
tained from a tracheal sample (T101) was found on a com-
mon branch with bovine coronavirus, human coronavirus-
OC43, and hemagglutinating encephalomyelitis virus.
The virus was provisionally called canine respiratory
coronavirus (CRCV).
Sequencing of the spike gene
For further analysis of the RNA sequence of CRCV, an
alignment of the RNA for the spike gene of the bovine
coronavirus LY 138 strain and the human coronavirus
OC43 strain was performed. Consensus regions were cho-
sen for the selection of four primer pairs amplifying the
complete spike gene in four overlapping fragments; the
primer sequences are shown in Table 1. The cDNA obtained
from tracheal sample T101 was used to perform RT–PCR
and subsequent sequencing of the obtained spike fragments.
The analysis of the sequencing data showed that the spike
gene of CRCV is 4092 nucleotides long, corresponding to
1093 amino acids. It was determined that the cDNA se-
quence obtained from tracheal sample T101 had a 97.312%
nucleotide identity with the spike gene of bovine coronavi-
rus strain LY138 (GenBank Accession No. AF058942) and
96.921% identity with that of human coronavirus strain
OC43 (GenBank Accession No. Z32768) in an overlap of
4092 nucleotides. When comparing the amino acid se-
quence obtained by translation of the cDNA sequence from
Fig. 1. Consensus tree for cDNA sequences from a 251-nucleotide region
of the polymerase gene of 12 coronaviruses. The sequence obtained from
the canine respiratory coronavirus is designated T101. The numbers indi-
cate bootstrap values obtained by analysis of 100 data sets. BCV, bovine
coronavirus; CCV, canine coronavirus; FIPV, feline infectious peritonitis
virus; HEV, hemagglutinating encephalomyelitis virus; IBV, infectious
bronchitis virus; MHV, mouse hepatitis virus; OC43, human coronavirus
strain OC43; SDAV, sialodacryoadenitis virus; TCV, turkey coronavirus;
TGEV, transmissible gastroenteritis virus; 229E, human coronavirus strain
229E; T101, canine respiratory coronavirus (PCR product from tracheal
sample T101).
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T101 to the amino acid sequence of the BCV, HCV-OC43,
and canine enteric coronavirus spike proteins the identities
were 96, 95.2, and 21.2%.
PCR using primers for the hemagglutinin/esterase gene
Bovine coronavirus and other group 2 coronaviruses
contain an additional structural protein, the hemagglutinin/
esterase (HE). Because of the high similarity of CRCV with
BCV, we analyzed the presence of a HE gene in CRCV.
An alignment of the HE gene sequences of BCV and
HCV OC43 was used to design the primers HE1 and HE2
(Table 2). Four tracheal samples that had previously been
identified as positive for coronavirus RNA by RT–PCR with
primers for the spike gene were tested by RT–PCR with the
primer set for the HE gene. All four samples showed a PCR
band of the expected size (Fig. 2).
Detection of CRCV in tissue samples by RT–PCR and
association of PCR-positive samples with respiratory
signs
Using a nested set of primers for the spike gene (Sp1–2
and Sp3–4), tracheal and lung samples from 119 dogs were
analyzed for CRCV. Of these, 42 were from dogs with no
respiratory signs (grade 1), 18 dogs had shown mild respi-
ratory signs (grade 2), 46 had shown moderate (grade 3),
and 13 severe respiratory signs (grades 4 and 5). Grades 4
and 5 were merged due to the low case numbers in these
groups.
In total 32 tracheal samples (26.9%) and 20 lung samples
(16.8%) were found positive by nested RT–PCR. For eight
dogs a positive PCR result was obtained for both trachea
and lung. Table 3 shows the PCR results for coronavirus in
dogs with different grades of respiratory disease.
Sequence analysis of the nested PCR products obtained
from tracheal tissues of six different dogs showed identical
DNA sequences for all six cDNA samples.
Establishment of a serological assay for CRCV
Because of the homology of the spike gene region of
CRCV to the spike region of bovine coronavirus, an ELISA
antigen for BCV was used for serological analysis.
Sera from 5 dogs with no history of infectious respiratory
disease that had not been housed in the investigated kennel
were tested. The OD values ranged from 0.013 to 0.39,
with an average OD value of 0.154. Furthermore, sera from
30 dogs admitted to a veterinary clinic for various reasons
were tested for antibodies to coronavirus. Of these, 20
samples showed an OD of 0.4 (0.46 to 0.396) and 10
samples showed an OD of 1.0 (1.012 to 1.949). Samples
with an OD of 0.6 or above were subsequently considered
positive.
Comparison of the immune response to CRCV of dogs
with and without respiratory disease
The BCV antigen ELISA was performed using paired
sera of 111 dogs from the study kennel. Of these, 81 dogs
had shown symptoms of respiratory disease during a period
of 21 days and 30 had remained healthy.
Of the group of dogs which developed respiratory dis-
ease, 17 were positive for antibodies to CRCV on the day of
entry into the kennel and 64 were negative.
Of the 64 dogs in this group which had no detectable
antibodies to CRCV on day 1, 63 tested positive on day 21.
All 46 dogs of these 63 for which a sample on day 7 was
available tested negative on day 7. Therefore 63 dogs
showed a seroconversion during the study period, whereas
only 1 dog remained negative.
Of the 30 dogs that had remained healthy, 17 had anti-
bodies to CRCV on the day of entry. All of the 13 dogs that
were negative on day 1 tested negative on day 7 but showed
a seroconversion until day 21.
Thus, of 34 dogs that were positive for antibodies to
CRCV on arrival in the kennel, 17 developed respiratory
disease (50%), whereas of 77 dogs that were negative on
arrival, 64 developed respiratory signs during the study
period (83.1%) (Fig. 3).
Therefore dogs that had no antibodies to CRCV on entry
into the kennel had an increased probability of developing
respiratory disease (P  0.001).
Only 1 of the 77 dogs that were negative on arrival
Table 2
Primers designed from an alignment of the hemagglutinin/esterase genes
of BCV (GenBank Accession No. M84486) and HCV OC43
(GenBank Accession No. M76373)
Name Sequence Location in
BCV HE gene
HE 1 5-TAT-CGC-AGC-CTT-ACT-TTT-GT 418–437
HE 2 5-ACC-GCC-GTC-ATG-TTA-TCA-G 914–896
Table 1
Primers designed from an alignment of the spike genes of bovine
coronavirus (GenBank Accession No. AF058942) and human
coronavirus, OC43 (GenBank Accession No. L14643)
Name Sequence Location in
BCV spike
gene
Sp 1 5-CTT-ATA-AGT-GCC-CCC-AAA-CTA-AAT 1637–1660
Sp 2 5-CCT-ACT-GTG-AGA-TCA-CAT-GTT-TG 2258–2236
Sp 3 5-GTT-GGC-ATA-GGT-GAG-CAC-TG 1666–1686
Sp 4 5-GCA-ATG-CTG-GTT-CGG-AAG-AG 2107–2088
Sp 5 5-AAC-GGT-TAC-ACT-GTT-CAG-CC 931–950
Sp 6 5-CAA-GTA-AAT-GAG-TCT-GCC-TG 1121–1102
Sp 7 5-GGC-TGC-CAC-CTC-TGC-TAG-TC 2919–2938
Sp 8 5-ATT-GTT-AAA-TGC-ATT-AGC-AAT-AAG-C 3069–3045
SpF 5-TTT-TTG-ATA-CTT-TTA-ATT-TCC-TTA-CC 4–29
SpR 5-GTC-GTC-ATG-TGA-WGT-TTT-RAT-TAC 4089–4066
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remained negative during the study period of 21 days,
whereas 76 dogs showed a seroconversion.
Serology using canine enteric coronavirus (CECV)
antigen
An ELISA assay using a canine coronavirus antigen was
performed to investigate whether CRCV showed a serolog-
ical cross-reaction to canine enteric coronavirus. Sera from
27 dogs, previously tested for antibodies to CRCV using the
BCV antigen, were selected.
It was found that 8 dogs had antibodies to CECV on the
day of entry into the kennel; of these 4 also had antibodies
to CRCV. Nineteen dogs were found to be negative for
CECV on day 1; 17 of these were also negative for CRCV.
Of the 19 negative dogs, 5 showed a seroconversion to
CECV during the 21-day period of the investigation and 17
showed a seroconversion to CRCV.
Analysis of the prevalence of respiratory disease in this
group showed that 6 of the 8 dogs (75%) that were positive
for antibodies to CECV on day 1 developed respiratory
disease. Of the group of 19 dogs that had no detectable
antibodies to CECV on day 1, 15 showed signs of respira-
tory disease (78.9%) (P  0.594).
Virus isolation
Tracheal tissue samples from five dogs that had been
identified as positive for coronavirus RNA by RT–PCR
were inoculated on cell cultures of canine adult lung fibro-
blasts and MDCK cells. For three samples virus isolation
was also attempted on A72 cells. The cultures showed no
signs of a cytopathic effect during three passages. After the
third passage, RNA was extracted from the cultures and
found to be negative for coronavirus by RT–PCR.
Discussion
This study reports the detection of a canine coronavirus,
provisionally called CRCV, in kenneled dogs with respira-
tory disease.
Coronaviruses have been reported to cause respiratory
disease of man, cattle, swine, and poultry, but their presence
in the respiratory tract of dogs and a possible association
with CIRD has not been determined. Only one study has
mentioned the isolation of canine coronavirus from four
dogs with symptoms of respiratory disease (Binn et al.,
1979). Therefore it was investigated in this study whether
coronaviruses could be detected in dogs from a kennel with
a high prevalence of CIRD. The disease was endemic in this
kennel and could not be controlled by the use of vaccines
recommended against “kennel cough,” strongly suggesting
that additional agents were contributing to the disease syn-
drome observed. Samples taken from the respiratory tract of
these dogs were examined using RT–PCR primers directed
to the conserved polymerase gene of coronaviruses (Ste-
phensen et al., 1999). Analysis of the cDNA sequences
obtained from the canine samples revealed that CRCV had
the highest similarity with the polymerase gene of bovine
coronavirus (98.8%) and human coronavirus OC43 (98.4%)
Fig. 2. RT–PCR using consensus primers directed to the hemagglutinin/esterase gene of bovine and human coronavirus (strain OC43). The agarose gel
electrophoresis shows PCR products of the expected size of 497 bp for the positive control (BCV) and four tracheal samples (T90–T105). BCV, bovine
coronavirus positive control sample; A72, coronavirus-negative A72 cells; H2O, PCR mix without DNA; T90–T105, tracheal samples of study dogs; 1 kb,
molecular size standard (Promega).
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but only a very low similarity to the polymerase gene of the
enteric canine coronavirus (strain 1–71, 68.53% similarity).
Phylogenetic analysis of the polymerase sequences of 11
coronaviruses showed CRCV to be located on a common
branch with 3 group 2 viruses: bovine coronavirus (BCV),
human coronavirus strain OC43 (HCV-OC43), and hemag-
glutinating encephalomyelitis virus. However, canine en-
teric coronavirus, a group 1 coronavirus, was shown to be
only distantly related.
Canine respiratory coronavirus therefore is a novel coro-
navirus of dogs that is most closely related to BCV and
HCV-OC43, both of which are known to cause respiratory
disease.
Sequence analysis of the spike gene confirmed the high
similarity of CRCV with BCV and HCV-OC43, both of
which are members of the group 2 of the Coronaviridae
family. Group 2 coronaviruses contain an additional struc-
tural protein, HE. We were able to demonstrate the presence
of a HE gene in the cDNA obtained from canine tracheal
samples by PCR. CRCV therefore has a HE gene and
belongs to group 2 of the coronavirus family.
Attempts to isolate CRCV from tissue of the respiratory
tract, using either canine lung fibroblasts or a kidney epi-
thelial cell line, have been unsuccessful so far. However, the
isolation of CRCV may require the use of fetal canine cells
or tracheal organ culture. Also it is possible that the virus
was inactivated during storage or due to freezing and thaw-
ing.
By PCR, CRCV was detected in tracheal and lung tissue
and therefore appears to infect the upper and lower respi-
ratory tracts of dogs. The possible presence of viral RNA in
other tissues needs to be analyzed in further studies and the
target cells of CRCV have to be identified using in situ
hybridization or immunohistochemistry.
The presence of antibodies to CRCV was analyzed using
an ELISA based on a BCV antigen because of the high
sequence similarity of the two viruses in the spike gene and
because CRCV antigen could not be obtained by virus
culture. The ELISA results confirmed the presence of a
virus similar to BCV in the study population.
The prevalence of antibodies was 30% at the time of
entry into the kennel and 99% after 21 days. Almost all dogs
negative on the day of entry into the kennel showed a
seroconversion to CRCV within 3 weeks, indicating that the
virus is highly contagious.
Serology using an antigen for CECV showed a much
lower prevalence of antibodies to CECV on day 21. There-
fore the BCV ELISA results did not reflect an infection with
canine enteric coronavirus and the cross-reactivity between
the two antigens seems to be low. Serum antibodies to
CRCV were present in about 30% of dogs of various ori-
gins, including dogs entering a rehoming kennel as well as
pet dogs. The presence of CRCV is therefore not limited to
the investigated kennel and the virus seems to be established
in the dog population.
Within the kenneled population, CRCV RNA was de-
tected in 27.3% of dogs with all grades of respiratory dis-
ease as well as in 26.2% of dogs that were apparently
healthy at the time of euthanasia. However, CRCV RNA
was most frequently found in the trachea of dogs with mild
cough (55%). Studies using the human coronavirus strain
229E have shown that coronaviruses can cause disruption of
the respiratory epithelium and ciliary dyskinesia (Chilvers
et al., 2001). If one supposes that an infection with CRCV
may have a similar effect then the virus could play an
important role in the early stages of the pathogenesis of
CIRD. By damage of the respiratory epithelium and disrup-
tion of the ciliary clearance CRCV could facilitate the entry
of other viral or bacterial pathogens causing the more severe
respiratory symptoms. The less frequent detection of CRCV
in tissue samples from dogs with more severe disease may
be explained by the destruction of the respiratory epithelium
by other microorganisms in the advanced stages of CIRD.
At the same time it is likely that the immune response that
is induced by CRCV in almost all dogs would help to clear
the infection, causing the prevalence of CRCV RNA to be
lower in later stages of the disease.
Furthermore, serological analysis revealed that dogs with
antibodies to CRCV on the day of entry into the kennel
developed respiratory disease less frequently than dogs
Table 3
RT–PCR results for tracheal and lung samples
Respiratory
signs
Trachea positive
samples
Lung positive
samples
Trachea and lung
positive samples
None 11/42 (26.2%) 8/42 (19.1%) 2/42
Mild 10/18 (55.6%) 4/18 (22.2%) 4/18
Moderate 9/46 (19.6%) 8/46 (17.4%) 2/46
Severe 2/13 (15.4%) 0/13 0/13
RT–PCR results from tracheal and lung samples of 119 dogs with
different respiratory signs (none to severe) using a nested PCR directed
against the coronavirus spike gene. The table shows the number of positive
samples out of total sample number and the percentage of positive samples
in parentheses.
Fig. 3. Comparison of the prevalence of respiratory disease in two groups
of dogs: Dogs in group 1 were positive for serum antibodies to respiratory
coronavirus on the day of entry into the kennel; dogs in group 2 were
negative. The graph shows the percentage of dogs developing respiratory
disease in group 1 compared to group 2 (P  0.001). N is the total number
of dogs in each group.
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without antibodies (P  0.001). Therefore the presence of
antibodies to CRCV had a protective effect against respira-
tory disease in this population, indicating a possible role of
the virus in the pathogenesis of CIRD. However 50% of the
dogs that were seropositive for CRCV on day 1 still devel-
oped respiratory disease. It was not determined if dogs
which developed disease had lower antibody titers than
those that stayed healthy as the ELISA was performed using
a single serum dilution. Alternatively, the disease in sero-
positive dogs may well have been caused by other respira-
tory pathogens present in this population. Studies determin-
ing the prevalence of other pathogens are currently under
way.
As CIRD is a complex disease involving a variety of
microorganisms, further epidemiological studies are re-
quired to determine the exact role of CRCV in this syn-
drome. It is likely that infections with CRCV alone may
cause only subclinical or mild respiratory symptoms but in
conjunction with other pathogenic agents severe respiratory
disease may occur. Alternatively, the presence of CRCV
may exacerbate disease caused by other agents.
This study describes the detection of a canine respiratory
coronavirus in dogs with CIRD, which is genetically and
antigenically distinct from the previously described enteric
coronavirus. The pathogenesis of “kennel cough” has not
been thoroughly investigated since the 1970s, when B.
bronchiseptica, canine adenovirus type 2, and canine para-
influenza were determined to be the main causes of the
disease. However, the vaccination of all dogs against CPIV,
CAV-2, and distemper virus did not help to control the
disease in this kennel despite evidence that the majority of
dogs responded to the vaccine within 21 days (data not
shown). A B. bronchiseptica vaccine had been used in the
past prior to this study but was discontinued because it
failed to protect against respiratory disease. Most rehoming
and training kennels frequently have to deal with outbreaks
of CIRD despite regular vaccination of all dogs. The aeti-
ology of CIRD therefore needs to be reevaluated and the
role of novel microorganisms or microorganisms previously
not associated with the disease should be established.
Materials and methods
Study population
Dogs from a well-established rehoming kennel with a
history of endemic respiratory disease were monitored for
this study. On entry into the kennel, all dogs were vacci-
nated with KAVAK DA2 PiP69 (Fort Dodge), a live atten-
uated vaccine for distemper virus, canine adenovirus type 2,
canine parainfluenzavirus, and canine parvovirus. Also, a
killed leptospirosis vaccine was used (Fort Dodge). The
health status of each dog was assessed twice a day by a
veterinary clinician and the respiratory signs were graded as
follows: (1) no respiratory signs, (2) mild cough, (3) cough
and nasal discharge, (4) cough, nasal discharge, and inap-
petence, (5) evidence of bronchopneumonia. The overall
health status of the dogs was graded as follows: (1) good
health, (2) poor health, (3) very poor health. The age, breed,
and sex of the dogs were recorded.
One hundred and nineteen dogs from the kennel popu-
lation were euthanased for welfare reasons, ranging from
behavioral problems to signs of severe respiratory disease
For these dogs, a full postmortem examination was per-
formed. The tissue samples were stored at 70°C until
further use.
Serum samples were collected from 111 dogs on the day
of entry into the rehoming kennel. For 81 dogs a follow-up
serum was available on day 7 and for 111 dogs a serum was
available on day 21 after entry. Of the 111 dogs, 30 re-
mained healthy during the 21 days between the first and the
last serum samples, whereas 81 dogs developed respiratory
disease.
Sera from 35 dogs housed elsewhere were obtained from
the diagnostic service of the Royal Veterinary College.
These sera had been submitted for biochemical analysis for
various reasons. Five of these sera were from 18-month-old
beagles with no history of respiratory disease. Sera were
routinely stored at 20°C.
RNA extraction and RT–PCR
RNA was extracted from tracheal and lung tissue of 119
dogs using TriReagent (Sigma). Approximately 25–50 mg
of homogenized tissue was used and RNA was extracted as
recommended by the manufacturer.
Synthesis of cDNA was performed using Random Hex-
ameres (Roche) and ImPromII reverse transcriptase (Pro-
mega).
For the detection of coronaviruses a modification of the
primers 2Bp and 4Bm directed against the polymerase gene
as described by Stephensen et al. (1999) were used (Con-
scoro5, 5-ACT-CAR-ATG-AAT-TTG-AAA-TAT-GC; Con-
scoro6, 5-TCA-CAC-TTA-GGA-TAR-TCC-CA).
PCR was performed using Taq polymerase (Promega) in
the provided reaction buffer containing a final concentration
of 2.5 mM MgCl2 and 0.5 M primers. For PCR with the
primers Conscoro5 and Conscoro6 the following tempera-
ture profile was used: After denaturation at 95°C for 5 min,
10 cycles were carried out at 95°C for 1 min, annealing at
37°C for 1 min, and extension at 72°C for 1 min. This was
followed by 10 cycles using an annealing temperature of
45°C, 10 cycles at an annealing temperature of 50°C, and 10
cycles at an annealing temperature of 53°C, followed by a
final extension at 72°C for 10 min.
A 20-l fraction of the PCR product was analyzed on a
1.5% agarose gel and blotted onto a nylon membrane after
electrophoresis. The nylon membrane was hybridized with
an oligonucleotide probe specific for the PCR product at
37°C overnight (Probe Conscoro, AAG-TTT-TAT-GGY-
GGY-TGG-GA). The probe was 3A-tailed with digoxi-
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genin–dUTP and was detected using anti-digoxigenin con-
jugate and CSPD chemoluminescent substrate (Roche).
Primers for the HE gene were chosen using an alignment
of the HE genes of BCV strain LY-138 (GenBank Acces-
sion No. M84486) and HCV strain OC43 (GenBank Acces-
sion No. M76373). The sequence and location of the prim-
ers are shown in Table 2. The following temperature profile
was used for the PCR: denaturation at 95°C for 5 min,
followed by 35 cycles of 95°C for 1 min, 50°C for 40 s, and
72°C for 1 min, followed by a final extension at 72°C for 10
min. The expected size of the PCR product was 497 bp.
Primer sequences specific for the spike gene were de-
rived from an alignment of the spike region of bovine
coronavirus strain LY-138 (GenBank Accession No. AF
058942) and human coronavirus strain OC43 (GenBank
Accession No. L14643).
For sequencing of the complete spike gene the primers
Sp1–Sp8, SpF, and SpR were designed. Table 1 shows the
primer sequences. A PCR was performed using Pfu poly-
merase (Promega) and the following temperature profile:
denaturation at 95°C for 5 min, followed by 35 cycles of
95°C for 1 min, 50°C for 40 s, and 72°C for 3 min. The final
extension was performed at 72°C for 10 min.
The PCR products were separated on an agarose gel and
purified using the Qiaquick gel purification kit (Qiagen).
PCR products were cloned into the pT7blue2 blunt vector
(Novagen) and sequenced using the Thermo sequenase flu-
orescent labeled primer cycle sequencing kit with 7-deaza-
dGTP (Amersham Pharmacia) using Cy5-labeled primers.
For the detection of coronavirus RNA in tissue samples,
the cDNA was tested by PCR with the primers Sp1 and Sp2,
followed by a nested PCR using the primers Sp3 and Sp4
and 2 l of the product of the first amplification.
The temperature profile used was denaturation at 95°C
for 5 min, followed by 35 cycles of 95°C for 1 min, 55°C for
40 s, and 72°C for 1 min. The final extension was performed
at 72°C for 10 min. The nested PCR produced a 442-bp
fragment.
Phylogenetic analysis
Nucleic acid similarity searches were performed using
FASTA (Pearson, 1990), with a gap open penalty of 16 and
a gap extension penalty of 4. Protein similarities were de-
termined using FASTA or GCG (Genetics Computer
Group, Wisconsin, USA) with a gap open penalty of 8 and
a gap extension penalty of 2.
Sequence alignments were performed using ClustalX
(Thompson et al., 1997).
The phylogenetic relationship to known coronaviruses
was analyzed using the Phylip 3.6 package (Felsenstein,
1989). The alignments were followed by a bootstrap anal-
ysis using the Seqboot program. The data sets obtained were
used for a maximum parsimony analysis using the DNApars
program and a consensus tree was calculated using Con-
sense. The resulting trees were drawn using the Treeview
program (Page, 1996).
GenBank Accession numbers
The CRCV polymerase partial sequence has been as-
signed GenBank Accession No. AY150273; the CRCV
spike gene sequence has been assigned GenBank Accession
No. AY150272.
ELISA
ELISA antigen for bovine coronavirus or canine corona-
virus (Churchill Applied Biosciences, Huntingdon, UK)
was resuspended in PBS at the concentration recommended
by the manufacturer and incubated on 96-well plates (Fal-
con) overnight at 37°C. The plates were washed with PBS
and blocked with PBS containing 5% skimmed milk powder
for 30 min. The sera were diluted 1:100 in blocking buffer
and incubated on the plates for 1 h. After washing with
PBS/0.05% Tween 20 (Sigma), a peroxidase-labeled rabbit
anti-dog IgG conjugate (Sigma) was added (1:5000 in PBS/
0.05% Tween 20) for 1 h. The plates were incubated with
color substrate (OPD, Sigma) for 10 min and the reaction
was stopped by adding 2 M H2SO4. The adsorption was
determined in an ELISA photometer at 492 nm.
Virus culture
Virus isolation was attempted on canine adult lung fi-
broblasts (passages 3 to 7) and MDCK and A72 cells. The
lung fibroblasts were maintained in MEM with 20% fetal
calf serum (FCS); MDCK and A72 cells were maintained in
MEM with 5% FCS. Tracheal tissue samples (approx 25
mg) were homogenized using a scalpel and mixed vigor-
ously in 1 ml of MEM containing penicillin (100 U/ml),
streptomycin (0.1 mg/ml), amphotericin B (2.5 g/ml), and
trypsin (1 g/ml). The samples were centrifuged at 13,000
rpm for 10 min and the supernatant was used to inoculate
cell cultures. After 30 min at 37°C the supernatant was
removed and maintenance medium was added to the cul-
tures. The cultures were passaged three times in the absence
of a cytopathic effect. Then, RNA was extracted from the
cells and RT–PCR for coronavirus was performed using the
nested PCR for the spike gene.
Statistical analysis
The data were analysed using the 2 test or Fisher’s exact
test and P values below 0.05 were considered statistically
significant.
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